348 related articles for article (PubMed ID: 11845410)
1. Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.
Edelmann L; Dong J; Desnick RJ; Kornreich R
Am J Hum Genet; 2002 Apr; 70(4):1023-7. PubMed ID: 11845410
[TBL] [Abstract][Full Text] [Related]
2. Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.
Bargal R; Avidan N; Olender T; Ben Asher E; Zeigler M; Raas-Rothschild A; Frumkin A; Ben-Yoseph O; Friedlender Y; Lancet D; Bach G
Hum Mutat; 2001 May; 17(5):397-402. PubMed ID: 11317355
[TBL] [Abstract][Full Text] [Related]
3. The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations.
Bach G; Webb MB; Bargal R; Zeigler M; Ekstein J
Hum Mutat; 2005 Dec; 26(6):591. PubMed ID: 16287144
[TBL] [Abstract][Full Text] [Related]
4. Rapid one-step carrier detection assay of mucolipidosis IV mutations in the Ashkenazi Jewish population.
Hantash FM; Olson SC; Anderson B; Buller A; Chen R; Crossly B; Sun W; Strom CM
J Mol Diagn; 2006 May; 8(2):282-7. PubMed ID: 16645217
[TBL] [Abstract][Full Text] [Related]
5. Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV.
Wang ZH; Zeng B; Pastores GM; Raksadawan N; Ong E; Kolodny EH
Genet Test; 2001; 5(2):87-92. PubMed ID: 11551108
[TBL] [Abstract][Full Text] [Related]
6. Mucolipidosis type IV a rare genetic disorder: new addition to the Ashkenazi Jewish panel.
Gordon RM; Marchese T
J Midwifery Womens Health; 2004; 49(4):359-60. PubMed ID: 15236718
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of mucolipidosis type IV.
Slaugenhaupt SA
Curr Mol Med; 2002 Aug; 2(5):445-50. PubMed ID: 12125810
[TBL] [Abstract][Full Text] [Related]
8. Familial dysautonomia and the expansion of the Ashkenazi Jewish carrier screening panel.
Gilbert F
Genet Test; 2001; 5(2):83-5. PubMed ID: 11551107
[No Abstract] [Full Text] [Related]
9. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
[TBL] [Abstract][Full Text] [Related]
10. Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.
Edelmann L; Wasserstein MP; Kornreich R; Sansaricq C; Snyderman SE; Diaz GA
Am J Hum Genet; 2001 Oct; 69(4):863-8. PubMed ID: 11509994
[TBL] [Abstract][Full Text] [Related]
11. Mucolipidosis type IV.
Bach G
Mol Genet Metab; 2001 Jul; 73(3):197-203. PubMed ID: 11461186
[TBL] [Abstract][Full Text] [Related]
12. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.
Bassi MT; Manzoni M; Monti E; Pizzo MT; Ballabio A; Borsani G
Am J Hum Genet; 2000 Nov; 67(5):1110-20. PubMed ID: 11013137
[TBL] [Abstract][Full Text] [Related]
13. Mucolipidosis type IV: the origin of the disease in the Ashkenazi Jewish population.
Raas-Rothschild A; Bargal R; DellaPergola S; Zeigler M; Bach G
Eur J Hum Genet; 1999; 7(4):496-8. PubMed ID: 10352940
[TBL] [Abstract][Full Text] [Related]
14. Identification of the gene causing mucolipidosis type IV.
Bargal R; Avidan N; Ben-Asher E; Olender Z; Zeigler M; Frumkin A; Raas-Rothschild A; Glusman G; Lancet D; Bach G
Nat Genet; 2000 Sep; 26(1):118-23. PubMed ID: 10973263
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
[TBL] [Abstract][Full Text] [Related]
16. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.
Abeliovich D; Lavon IP; Lerer I; Cohen T; Springer C; Avital A; Cutting GR
Am J Hum Genet; 1992 Nov; 51(5):951-6. PubMed ID: 1384328
[TBL] [Abstract][Full Text] [Related]
17. A physical and transcript map of the MCOLN1 gene region on human chromosome 19p13.3-p13.2.
Acierno JS; Kennedy JC; Falardeau JL; Leyne M; Bromley MC; Colman MW; Sun M; Bove C; Ashworth LK; Chadwick LH; Schiripo T; Ma S; Goldin E; Schiffmann R; Slaugenhaupt SA
Genomics; 2001 Apr; 73(2):203-10. PubMed ID: 11318610
[TBL] [Abstract][Full Text] [Related]
18. Familial dysautonomia: detection of the IKBKAP IVS20(+6T --> C) and R696P mutations and frequencies among Ashkenazi Jews.
Dong J; Edelmann L; Bajwa AM; Kornreich R; Desnick RJ
Am J Med Genet; 2002 Jul; 110(3):253-7. PubMed ID: 12116234
[TBL] [Abstract][Full Text] [Related]
19. Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population.
Kornreich R; Ekstein J; Edelmann L; Desnick RJ
Genet Med; 2004; 6(5):415-20. PubMed ID: 15371906
[TBL] [Abstract][Full Text] [Related]
20. Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay.
Feigenbaum A; Moore R; Clarke J; Hewson S; Chitayat D; Ray PN; Stockley TL
Am J Med Genet A; 2004 Jan; 124A(2):142-7. PubMed ID: 14699612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
